ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >TGF-beta / Smad >TGF-beta / Smad inhibitors >GW788388

GW788388

GW788388 Suppliers list
Company Name: Dezhou LonWel Pharmaceutical Technology Co., Ltd.  Gold
Tel: 13761310616
Email: 39324283@qq.com
Company Name: Shanghai Boyle Chemical Co., Ltd.  
Tel:
Email: sales@boylechem.com
Company Name: J & K SCIENTIFIC LTD.  
Tel: 18210857532 18210857532
Email: jkinfo@jkchemical.com
Company Name: Chembest Research Laboratories Limited  
Tel: 021-20908456
Email: sales@BioChemBest.com
Company Name: Nanjing Chemlin Chemical Co., Ltd  
Tel: 025-83697070 13770331960
Email: info@chemlin.com.cn

GW788388 manufacturers

  • GW788388
  • GW788388 pictures
  • $58.00
  • 2026-07-27
  • CAS:452342-67-5
  • Purity: 99.58%
  • Supply Ability: 10g
  • GW788388
  • GW788388 pictures
  • 2026-07-06
  • CAS:452342-67-5
  • Min. Order: 1KG
  • Purity: 98%
  • Supply Ability: 20Tons
GW788388 Basic information
Product Name:GW788388
Synonyms:4-[4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl]-N-(tetrahydropyran-4-yl)benzamide;N-(oxan-4-yl)-4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}benzaMide;GW 788388 4-[4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl]-N-(tetrahydropyran-4-yl)benzamide;GW 788388;BenzaMide, 4-[4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-2-pyridinyl]-N-(tetrahydro-2H-pyran-4-yl)-;4-(4-(3-(Pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide;GW788388;GW 788388;GW 788388, >=98%
CAS:452342-67-5
MF:C25H23N5O2
MW:425.48
EINECS:
Product Categories:Inhibitors;Smad;TGF-beta
Mol File:452342-67-5.mol
GW788388 Structure
GW788388 Chemical Properties
density 1.34
storage temp. 2-8°C
solubility Soluble in DMSO (18 mg/ml with warming)
form solid
color Off-white
Stability:Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
Safety Information
MSDS Information
GW788388 Usage And Synthesis
DescriptionGW 788388 is a selective inhibitor of transforming growth factor-β (TGF-β) type 1 receptor (TGFBR1 or ALK5; IC50 = 18 nM). It inhibits the expression of collagen type I in cells (IC50 = 93 nM) and in mice when given orally at 10 mg/kg once a day. As TGF-β stimulates fibrosis in a range of tissues, GW 788388 reduces typical features of fibrosis, including tissue remodeling, increased expression of α-smooth muscle actin and production of collagen I. GW 788388 also blocks TGF-β-mediated production of VEGF by fibroblasts, as well as subsequent angiogenesis in vitro. Inhibition of ALK5 signaling by GW 788388 also induces hypertrophy in femoral growth plates in rats.
UsesGW788388 is a new TGF-beta type I receptor inhibitor with a much improved pharmacokinetic profile compared with SB431542.
in vivo

GW788388 given orally for 5 weeks significantly reduces renal fibrosis and decreased the mRNA levels of key mediators of extracellular matrix deposition in kidneys in db/db mice[1]. GW788388 (50 mg/kg/day, p.o.) significantly attenuates systolic dysfunction in the MI animals, together with the attenuation of the activated (phosphorylated) Smad2 (P < 0.01), α-smooth muscle actin (P < 0.001), and collagen I (P < 0.05) in the noninfarct zone of MI rats[2]. GW788388 reduces the expression of collagen IA1 by 80% at a dose of 1 mg/kg twice a day (b.i.d.). GW788388 significantly reduces the expression of collagen IA1 mRNA when administered orally at 10 mg/kg once a day (u.i.d.) in a model of puromycin aminonucleoside-induced renal fibrosis[3].

storageStore at +4°C
References[1] FRANÇOISE GELLIBERT. Discovery of 4-{4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): A Potent, Selective, and Orally Active Transforming Growth Factor-β Type I Receptor Inhibitor[J]. Journal of Medicinal Chemistry, 2006, 49 7: 2210-2221. DOI:10.1021/jm0509905
[2] M. PETERSEN . Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis[J]. Kidney international, 2008, 73 6: Pages 705-715. DOI:10.1038/sj.ki.5002717
[3] FABIANE L DE OLIVEIRA. Oral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas disease.[J]. PLoS Neglected Tropical Diseases, 2012: e1696. DOI:10.1371/journal.pntd.0001696
[4] KAZUHIRO NOMA . The Essential Role of Fibroblasts in Esophageal Squamous Cell Carcinoma–Induced Angiogenesis[J]. Gastroenterology, 2008, 134 7: Pages 1981-1993. DOI:10.1053/j.gastro.2008.02.061
[5] YUNMEE LHO. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.[J]. International Journal of Molecular Sciences, 2021, 22 9. DOI:10.3390/ijms22094739
GW788388 Preparation Products And Raw materials
Tag:GW788388(452342-67-5) Related Product Information
GW284543 GW9662 GW441756 GW5074 SB 431542 LY2109761 ALK5 inhibitor II Dabrafenib SB525334 LY 2157299 AZ20 Ibrutinib KU57788(NU7441) GW 284543 hydrochloride - UNC 10225170 hydrochloride 5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine GW9508 2,4-Thiazolidinedione, 5-[[5-[6-(4-acetyl-1-piperazinyl)-3-nitro-2-pyridinyl]-2-fluorophenyl]methylene]- N-Eicosanoyl Serotonin